The February launch would make Bharat Biotech’s Covid vaccine the first Indian-made vaccine to be launched New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, …
Read More »Covaxin, Bharat Biotech’s Covid Vaccine, Could Launch In February: Report
New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, a scientist from high level of government. Bharat Biotech, a private company developing COVAXIN with the …
Read More »Covaxin end-phase trials begin in Bhubaneswar – updates
Amid the race to develop a ‘potential’ vaccine against the novel coronavirus pandemic, the first Covid-19 vaccine developed in India, Covaxin will soon begin its Phase III clinical trials at a private hospital in Bhubaneswar, an official said. The search for a suitable vaccine for Covid-19 has almost reached the …
Read More »Indian Coronavirus Vaccine Update: When Will Bharat Biotech’s Covaxin Launch?
Bharat Biotech plans to conduct the third phase of trials with more than 20,000 volunteers in 12-14 states in India. Bharat Biotech’s own coronavirus vaccine from India, which was in the second stage of human clinical trials, has finally received the go-ahead for the last phase. The highly anticipated candidate …
Read More »Bharat Biotech obtains the rights for the covid nasal vaccine technology, eyes 100 crore doses
Hyderabad-based Bharat Biotech and US biotech firm Precision Virologics jointly obtained the rights from Washington University School of Medicine in St. Louis for a novel chimpanzee adenovirus vaccine against COVID-19. Bharat Biotech will own the rights to distribute the nasal covid vaccine, subject to regulatory approvals, in all markets except …
Read More »